TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.

Nicholas Kitchin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.